Richard S. Geary

Richard S. Geary

EVP, Chief Development OfficeratIonis Pharmaceuticals· In proxies 2021–2025

Pay in FY2025Ionis Pharmaceuticals stock +126.3% the same year

Richard S. Geary was paid $3.3M in FY2025 (Dec). Ionis Pharmaceuticals stock rose 126.3% that year.

Pay$100 in the stock at the end of FY20 → $202
Pay is from the Summary Compensation Table of each Ionis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ionis PharmaceuticalsPublic company · 5 yr
    • EVP, Chief Development Officer2021 – Present · 5 yrStock in role -25%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?